Abstract:Six new potentially bioactive organotin(IV) complexes were synthesized from the Schiff base ligand derived from phenylhydrazine and 5‐bromo‐2‐hydroxybenzaldehyde. Newly synthesized compounds showed antioxidant activity in the range of 57.68%–74.07%. All of the complexes displayed significant antimicrobial activity. The molecular docking results are consistent with in vitro studies. Six organotin(IV) complexes (1–6) were synthesized, following the general formulas as R2Sn(L)Cl and R3Sn(L), have been reported. In these complexes, L represents a Schiff base prepared by the reaction of phenylhydrazine with 5‐bromo‐2‐hydroxybenzaldehyde, and R = Me, n‐Bu, Ph. Various analytical techniques were employed to characterize and determine the structure of the newly synthesized compounds. The techniques, including the elemental analysis, molar conductivity measurements, UV–visible, FT‐IR, NMR spectroscopy, and mass spectrometry. Spectroscopic analysis suggested that the ligand (4‐bromo‐2‐[(2‐phenylhydrazinylidene)meth‐yl]phenol) (HL) coordinates with the tin (Sn) metal through its phenolic oxygen (O) and azomethine nitrogen (N) atoms. Molar conductivity measurements indicated that all the synthesized compounds are nonelectrolytes. The percent CHN analysis data also corroborates the spectroscopic results. UV–Vis spectra revealed the mode of transitions of electrons due to the π–π* transitions, n–π* transitions, and transitions involving charge transfer from the ligand to the metal, which occurred in recently developed ligand and organotin (IV) complexes. The emergence of additional bands in the FT‐IR spectra of complexes (1–6), attributed to ν(Sn–O) and ν(Sn–N), which were absent in the precursor, offers further proof for the synthesis of these complexes. NMR spectral studies give information about the nature and number of all protons having the same or different chemical environment in the structure of all the compounds being reported in this study. The potential to be used as bioactive compounds in the future was assessed by performing the biological activities (antimicrobial and antioxidant) of these synthesized compounds and the DPPH free radical method for the antioxidant potential of these compounds. Based on these assessments, it can be concluded that the ligand's efficiency improves upon complexation, primarily due to the type and quantity of alkyl groups attached to the [Sn] metal atom. ADME and studies were conducted to forecast the biological effectiveness of the ligand and its metal complexes. Among these, the ligand and complexes 1 and 4 are prioritized for docking with Aspergillus flavus, Bacillus subtilis, and Escherichia coli. The complexes 1 and 4 were found biologically more effective towards different microbes. The Antioxidant activity of the test complexes follows this trend: Methyltin(IV) complexes exhibit the lowest activity, whereas butyltin(IV) and phenyl(IV) complexes exhibit higher levels of activity, with phenyltin(IV) showing the most significant activity.

Synthesis, Characterization and Biological Activity of Diorganotin(IV) Complexes of N‐(3,5‐Dibromo‐salicylidene)‐ Α‐amino Acid

Synthesis, Structural Characterization, and Properties of Triorganotin Complexes of Schiff Base Derived from 3‐aminobenzoic Acid and Salicylaldehyde or 2,4‐Pentanedione

Synthesis and Structural Characterization of Some Diorganotin Complexes of N-(3,5-Dibromosalicylidene)-α-amino Acid and Their Diphenyltin Dichloride Adducts

Synthesis, Characterization and Biological Activity of a Novel Binuclear Organotin Complex, Ph3Sn(HL)·Ph2SnL [L = 3,5-Br2-2-oc6h2chnch(i-pr)coo]

“S” Shaped Organotin(iv) Carboxylates Based on Amide Carboxylic Acids: Syntheses, Crystal Structures and Antitumor Activities

Synthesis, characterization, in vitro antioxidant and antimicrobial activities of diorganotin(IV) complexes derived from hydrazide Schiff base ligands

Di‐ and Tri‐organotin(iv) Derivatives of (z)‐3‐(4‐nitrophenyl)‐2‐phenyl‐2‐propenoic Acid: Spectroscopic Characterization and Biocidal Studies. Crystal Structure Analysis of Tetrameric Tri‐n‐butyltin(iv) (Z)‐3‐(4‐nitrophenyl)‐2‐phenyl‐2‐propenoate

Organotin(IV) Complexes Derived from Hydrazone Schiff Base: Synthesis, Crystal Structure, in Vitro Cytotoxicity and DNA/BSA Interactions

New Tin (IV) and Organotin (IV) Complexes with a Hybrid Thiosemicarbazone/Hydrazone Ligand: Synthesis, Crystal Structure, and Antiproliferative Activity

Organotin(IV) complexes derived from 2,6-diacetylpyridine bis(2-hydroxybenzoylhydrazone) as prospective anti-proliferative agents: Synthesis, characterization, structures and in vitro anticancer activity

Four organotin(IV) complexes derived from 2,6-difluoro-3-(propylsulfonamido)benzoic acid: synthesis, structure, in vitro cytostatic activity and antifungal activity evaluation

Synthesis, structural elucidation and anticancer activity of diorganotin(IV) complexes derived from isonicotinoyl hydrazones

SYNTHESIS AND CHARACTERIZATION OF ORGANOTIN(IV) COMPLEXES OF N-(2-MERCAPTOPHENYL)-SALICYLALDIMINE

Diorganotin(IV) Derivatives of N-Methyl p-Fluorobenzo-Hydroxamic Acid: Preparation, Spectral Characterization, X-ray Diffraction Studies and Antitumor Activity

New Organotin (IV) Compounds Derived from Dehydroacetic Acid and Thiosemicarbazides: Synthesis, Rational Design, Cytotoxic Evaluation, and Molecular Docking Simulation

Comprehensive Investigation of Organotin(IV) Complexes Derived From a Novel Schiff Base: Synthesis, Characterization, Antioxidant, ADME Profiling, and In Vitro Biological Evaluation

Synthesis , crystal structure and biological activities of four novel tetranuclear di-organotin ( IV ) carboxylates q

Five organotin complexes derived from hydroxycinnamic acid ligands: Synthesis, structure, in vitro cytostatic activity and binding interaction with BSA

Synthesis, Characterization, Biological Activity and Molecular Docking Studies of Novel Organotin(IV) Carboxylates

Synthesis, Characterization, and In Vitro Antimicrobial and Antioxidant Study of the Pentacoordinated Organotin(IV) Complexes Based on Acid Hydrazide Schiff Base Ligands

Diorganotin (IV) amino acid complexes as potential anticancer agents. Synthesis, structural characterization, and in vitro assays